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Abstract
Background: Type 2 diabetes is a complex metabolic disorder with obesity being a major contributing factor in its
development. Susceptibility loci for type 2 diabetes and obesity have been localized on different chromosomal
regions by various genome-wide linkage scans. Of these chromosomal regions, 20q13 is one of the strongest linked
regions for type 2 diabetes as well as obesity. On 20q13 lies DOK5 that seems to be a strong functional and
positional candidate for type 2 diabetes and obesity because of its involvement in insulin signaling and immune
responses. Hence, for the first time, we explored DOK5 as a potential type 2 diabetes and obesity susceptibility gene.
Methods: We sequenced 43 subjects for polymorphisms in functionally relevant regions of DOK5. A total of 10
SNPs that included 5 that were identified by sequencing and 5 additional SNPs from NCBI Variation Database were
genotyped in 2,115 participants comprising of 1,073 patients with type 2 diabetes and 1,042 controls of Indo-
European ethnicity from North India.
Results: We identified a novel variant in intron 7 referred to as DK176673. We found nominal association of three
SNPs-rs6064099 (OR = 0.75, P = 0.019), rs873079 (OR = 0.76, P = 0.036) and DK176673 (OR = 1.55, P = 0.037) with
type 2 diabetes among normal-weight subjects [BMI < 23 kg/m
2]. The haplotype GGC harboring rs6068916,
rs6064099 and rs873079 showed strong association with type 2 diabetes among normal-weight subjects (OR =
1.37, P/Pperm = 5.8 × 10
-3/0.037). Association analysis with obesity revealed that rs6064099 is associated with
reduced susceptibility for obesity (OR = 0.48, P = 6.8 × 10
-3). Also, haplotype GGC conferred increased susceptibility
for obesity (OR = 1.27, P/Pperm = 9.0 × 10
-3/0.039). Also, rs6064099 was significantly associated with reduced BMI
[median(IQR) = 24.0(20.7-27.1) vs 23.9(20.2-26.8) vs 21.8(19.2-24.7) for GG vs GC vs CC, P = 7.0 × 10
-3].
Conclusions: We identified DOK5 as a novel susceptibility gene for obesity and type 2 diabetes in North Indian
subjects. Association of DOK5 variants both with obesity and type 2 diabetes suggests that these variants might
modulate type 2 diabetes susceptibility through obesity.
Background
Type 2 diabetes is a complex metabolic disorder charac-
terized by impaired insulin secretion and action. Obesity
is one of the major contributing factors in the develop-
ment of type 2 diabetes. Though believed to be overlap-
ping, the etiology of both type 2 diabetes and obesity
are unclear. Gene identification is an important
milestone in the understanding of disease pathophysiol-
ogy, but has proven to be a difficult task for complex
disorders such as type 2 diabetes. Multiple susceptibility
loci on different chromosomal regions are believed to be
involved in genetic etiology of type 2 diabetes.
Evidence for localization of susceptibility loci on dif-
ferent chromosomal regions for type 2 diabetes and obe-
sity has been provided by various genome-wide linkage
scans. Of these regions, 20q13 is one of the strongest
candidate regions for type 2 diabetes which is documen-
ted to be linked to type 2 diabetes by more than 8
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same region has also been shown to be linked to obesity
by various studies [10-12]. However, till date there has
been no clear evidence for localization of type 2 diabetes
and obesity susceptibility genes on this region. Hence,
exploration of 20q13 through positional candidate
approach may facilitate identification of susceptibility
genes for type 2 diabetes and obesity on this region.
The region 20q13 harbors DOK5 that encodes Dok5
which belongs to the Downstream of Kinases (DOK)
family containing tandem pleckstrin homology-phospho-
tyrosine binding (PH-PTB) domains at the N-terminal.
Although the biological function of this docking protein
is not very clear, Dok5 is shown to be one of the sub-
strates in insulin signaling [13]. Dok5 contains a short
C-terminus with potential sites for tyrosine phosphory-
lation that get phosphorylated in response to insulin
and IGF1 [13]. Moreover, the highest expression of
Dok5 has been detected in skeletal muscle which is the
major tissue regulating metabolic homeostasis. Dok5 is
also suggested to be involved in the regulation of
immune response induced by T cells [14].
Because of its involvement in insulin signaling and
immune responses which are the key modulating path-
ways in type 2 diabetes and obesity, DOK5 seems to be
a convincing positional and functional candidate for
type 2 diabetes and obesity. Therefore, here for the first
time, we explored DOK5 as a potential type 2 diabetes
and obesity susceptibility gene in North Indian popula-
tion which has a high risk of developing type 2 diabetes.
Methods
Subjects’ recruitment
A total of 2,115 unrelated subjects comprising of 1,073
patients with type 2 diabetes and 1,042 control sub-
jects from North India belonging to Indo-European
ethnicity were enrolled after obtaining written
informed consent. Type 2 diabetic patients were
recruited from Endocrinology clinic of All India Insti-
tute of Medical Sciences, New Delhi between the per-
iod of 2003 and 2008. Diagnosis of type 2 diabetes was
done as per WHO criteria 2003 [15]. The control sam-
ples were collected by organizing ‘Diabetes Awareness
Camps’ in the urban regions in and around Delhi. Sub-
jects of ≥40 years of age without family history of dia-
betes who had glycated hemoglobin (HbA1c) level
≤6.0% and fasting glucose level <110 mg/dL were con-
sidered as controls. Detailed description of inclusion
and exclusion criteria for cases and controls is pro-
vided previously [16]. Study was in accordance with
the principles of the Helsinki Declaration and was
approved by the Ethics Committees of the participating
institutions.
Anthropometric and biochemical characterization
All the recruited subjects underwent anthropometric
and biochemical measurements. Height, weight, waist
and hip circumferences, and blood pressure were mea-
sured following standard guidelines before drawing
blood. Body mass index (BMI) and waist to hip ratio
(WHR) were calculated from these measurements.
Based on their BMI, the subjects were categorized into
two groups according to the BMI cut-offs for Asian
populations: normal-weight (BMI < 23 kg/m
2) and over-
weight/obese subjects (BMI ≥23 kg/m
2)[ 1 7 ] .V e n o u s
blood samples were drawn after overnight fasting for
biochemical measurements. Levels of glucose, HbA1c,
insulin, C-peptide, total cholesterol, triglycerides (TG),
high-density lipoprotein cholesterol (HDL-C), low-den-
sity lipoprotein cholesterol (LDL-C), urea, uric acid,
creatinine and hsCRP were measured as described ear-
lier [16,18].
Screening and identification of polymorphisms
To identify novel variants if any, we sequenced approxi-
mately 5 kb region of DOK5 including all exons, exon-
intron boundaries, putative promoter and UTRs in 43
samples of Indian Discovery panel [19]. Primers used
were designed by Primer3 http://frodo.wi.mit.edu/primer3
that provides better primer design [20]. In the sequenced
samples, we captured 9 SNPs including one novel variant
in intron 7 (chromosomal position 53,266,929) that has
never been reported earlier (referred here as DK176673)
(Figure 1). From these, 5 SNPs (rs6098099, rs6068915,
rs6064099, DK176673, rs2840) were selected for further
genotyping. As SNPs in 3’UTR were very close, only one
SNP (rs2840) was genotyped. Additionally, five more
SNPs from NCBI Variation Database that includes
rs6098009, rs6023307, rs6023357, rs6023367 and
rs873079 were selected to cover the entire gene based on
the selection criteria that includes functional significance,
heterozygosity (MAF >0.05),i n f o r m a t i o nr e g a r d i n gt a g
SNPs and distance between the SNPs.
Genotyping
Genotyping of these 10 SNPs was performed using
GoldenGate assay on Illumina platform (Illumina Inc.,
San Diego, CA, USA). The genotyping data obtained
was subjected to extensive quality control that includes
genotype confidence score of 0.25, call frequency >0.9,
GenTrans score >0.6, cluster separation score >0.4,
MAF > 0.05 and Hardy-Weinberg equilibrium (HWE) in
controls (P > 0.01). Of the total case-control samples, 90
DNA samples had genotype call for less than 90% of the
SNPs and hence were excluded. A total of 147 samples
(7%) were genotyped in duplicates and showed a consis-
tency rate of 99.99% in genotype calls. SNP rs2840 failed
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mass spectrometry (Sequenom, San Diego, CA, USA).
Statistical Analysis
Deviation from HWE at each locus was tested both
among cases and controls separately using c
2 analyses.
Association of genotypes with type 2 diabetes and obe-
sity was assessed by logistic regression. Association ana-
lyses of genotypes with type 2 diabetes were also
performed after stratification of cases and controls into
normal-weight and over-weight/obese subjects. The ana-
lyses were adjusted for age, sex and BMI as appropriate.
Odds ratios (ORs) are presented with respect to the
minor alleles. Bonferroni correction was applied to cor-
rect for multiple comparisons and a P value <0.008 was
considered significant after correction. The uncorrected
P values are provided in the text. Association between
genotypes and quantitative traits was determined using
Kruskal-Wallis test only in control subjects. Haplotype
analysis was carried out at 10,000 permutations using
Haploview 4.0 [21]. Statistical power was determined
using PS power and sample size program [22]. Our sam-
ple provided power of 69%-97% to detect association
with ORs of 1.3-1.5 assuming MAF of 0.20 at level of
significance of 0.05. The statistical analyses were per-
formed using SPSS version 17.0 (SPSS, Chicago, IL,
USA) and PLINK v. 1.05 http://pngu.mgh.harvard.edu/
~purcell/plink[23].
Results
DOK5 polymorphisms
We identified a total of 9 SNPs after sequencing the
functionally significant regions of DOK5 including one
novel SNP in intron 7 (referred as DK176673) and 8
reported SNPs-rs6098099 (Intron 5), rs6068915 (Intron
5), rs6064099 (Intron 6), rs2840 (5’UTR), rs2842
(5’UTR), rs2841 (5’UTR), rs15899 (5’UTR) and rs2843
(5’UTR) (Figure 1). As the 5 SNPs identified in 5’UTR
region were very close to each other, only one (rs2840)
was selected for further genotyping. Hence, of the 9
identified SNPs, 5 SNPs- rs6098099, rs6068915,
rs6064099, DK176673, rs2840 were selected for further
genotyping. Additionally, five more SNPs from NCBI
Variation database that includes rs6098009 (Intron 1),
rs6023307 (Intron 1), rs6023357 (Intron 2), rs6023367
(Intron 2) and rs873079 (Intron 7) were also selected
for the complete coverage of gene region.
DOK5 polymorphisms and type 2 diabetes
A total of 10 SNPs were genotyped in the study popula-
tion of 2,115 participants comprising of 1,073 patients
with type 2 diabetes and 1,042 controls of Indo-Eur-
opean ethnicity from North India. The clinical charac-
teristics of the study population are provided in Table 1.
All the SNPs were in accordance with HWE (all P >
0.01) both among cases and controls, except for rs2840
that was eliminated from further analysis. SNPs-
rs6098009, rs6023307 and rs6098099 were found to be
rare variants (MAF < 0.05) and were consequently
excluded under the paradigm of a CVCD model. None
of the DOK5 variants analyzed here showed association
with type 2 diabetes (Table 2).
Obesity is a well known risk factor of type 2 diabetes
and influence of BMI on the risk of development of
type 2 diabetes has been consistently shown in number
of studies [24]. Recently, we also showed variability in
the risk of type 2 diabetes among individuals in different
BMI strata [16,25]. This implies that the etiology of type
2 diabetes might be different in normal-weight indivi-
duals and overweight/obese individuals. Therefore, we
segregated the subjects into two groups based on BMI:
Normal-weight (BMI < 23 kg/m
2) and overweight/obese
(BMI ≥ 23 kg/m
2). Type 2 diabetes patients among nor-
mal-weight and over-weight/obese groups had median
age of 55 years with median BMI of 21.3 kg/m
2 and 53
years of median age with median BMI of 26.5 kg/m
2
Figure 1 Gene structure of DOK5 representing SNPs identified in Indian population and selected for association analysis. SNPs marked
with arrow were selected for association analysis. * indicates the SNPs selected from NCBI variation databases while other SNPs were identified
by direct sequencing of the gene.
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and over-weight/obese groups had median age of 50
years with median BMI of 20.0 kg/m
2 and 50 years of
median age with median BMI of 26.4 kg/m
2 respectively.
Then, we compared the allelic and genotypic distribu-
tions among normal-weight cases and controls; and
overweight/obese cases and controls (Table 2). We
observed nominal association of rs6064099 and
rs873079 among normal-weight subjects [OR = 0.75
(P = 0.019) and 0.76 (P = 0.036)]. The association did
not remain significant after adjusting for age, sex and
BMI. Also, DK176673 was found to confer susceptibility
to type 2 diabetes (OR = 1.55, P = 0.037) that was
retained after adjustments for covariates (P = 0.043) but
did not after applying multiple testing correction.
Among over-weight/obese subjects, none of the SNPs
showed significant effect on type 2 diabetes
susceptibility.
SNPs rs6064099 and rs873079 were in strong LD
(D’ = 0.98 and r
2 = 0.91). Among normal-weight indivi-
duals, haplotype GGC harboring major alleles of
rs6068916, rs6064099 and rs873079 was more frequent
among type 2 diabetes patients (66.9%) as compared to
control subjects (59.8%). The GGC haplotype was found
to confer increased susceptibility for type 2 diabetes
(OR = 1.37, P/Pperm =5 . 8×1 0
-3/0.037) among normal-
weight individuals (Table 3). Another haplotype CTT
encompassing rs6064099, rs873079 and DK176673
showed reduction in type 2 diabetes susceptibility
Table 1 Anthropometric and clinical characteristics of the
study population
Characteristics Type 2 diabetic
patients
Control
subjects
N (Men/Women) 1019 (592/427) 1006 (606/400)
Age (years) 53 (45-62) 50 (44-60)
BMI (Kg/m
2)
Men 23.8 (22.0-26.0) 23.1 (20.1-25.7)
Women 26.7 (24.2-29.2) 25.0 (21.1-28.5)
WHR
Men 1.0 (0.97-1.03) 0.97 (0.92-1.0)
Women 1.0 (0.97-1.03) 0.86 (0.82-0.92)
Systolic BP (mmHg) 130 (130-140) 120 (112-132)
Diastolic BP (mmHg) 80 (78-90) 80 (70-88)
HbA1c (%) 7.8 (6.5-9.4) 5.2 (4.9-5.6)
Fasting Glucose (mmoles/L) 7.9 (6.4-10.3) 4.9 (4.5-5.3)
Fasting Insulin (μU/mL) 13.8 (7.0-27.8) 5.4 (2.9-9.6)
HOMA-IR 5.2 (2.3-9.6) 1.2 (0.6-2.0)
C-peptide (ng/mL) 2.7 (1.7-4.1) 1.6 (1.1-2.2)
hsCRP (mg/L) 2.2 (0.9-4.7) 1.3 (0.6-3.0)
Total cholesterol (mg/dL) 163 (137-195) 170 (146-199)
LDL-C (mg/dL) 100 (77-130) 108 (90-132)
HDL-C (mg/dL) 40 (35-48) 41 (34-50)
TG (mg/dL) 138 (100-198) 117 (86-161)
Urea (mg/dL) 26 (20-33) 24 (19-29)
Uric acid (mg/dL) 4.9 (3.9-6.0) 4.9 (4.0-5.7)
Creatinine (mg/dL) 0.84 (0.67-1.07) 0.75 (0.66-0.88)
Data are median values with interquartile ranges in parentheses.
Table 2 Association of DOK5 SNPs with type 2 diabetes in North Indian population
SNP Entire Sample set Normal-weight subjects Over-weight/obese subjects
Case: Control
(1019: 1006)
OR
(95%CI)
P value
ORadj
(95%CI)
Padj value
Case: Control
(295: 436)
OR
(95%CI)
P value
ORadj
(95%CI)
Padj value
Case: Control
(691: 561)
OR
(95%CI)
P value
ORadj
(95%CI)
Padj value
rs6023357 (A/C) 814: 822
196: 165
7: 16
1.06
(0.86-1.30)
0.597
1.10
(0.90-1.36)
0.355
236: 351
56: 77
1: 6
0.96
(0.68-1.36)
0.825
0.95
(0.65-1.39)
0.799
548: 465
137: 87
6: 9
1.17
(0.90-1.52)
0.246
1.16
(0.89-1.50)
0.276
rs6023367 (G/A) 794: 792
218: 202
7: 11
1.03
(0.84-1.25)
0.810
1.06
(0.86-1.29)
0.606
223: 341
70: 92
2: 3
1.14
(0.82-1.60)
0.432
1.19
(0.83-1.71)
0.335
548: 446
138: 107
5: 8
0.97
(0.75-1.26)
0.838
0.97
(0.75-1.26)
0.829
rs6068915 (C/T) 772: 759
229: 217
17: 28
0.95
(0.79-1.13)
0.533
0.95
(0.79-1.13)
0.562
226: 324
63: 98
6: 14
0.87
(0.65-1.17)
0.361
0.91
(0.66-1.24)
0.538
525: 430
154: 116
11: 14
0.99
(0.79-1.25)
0.940
0.97
(0.77-1.23)
0.830
rs6064099 (G/C) 589: 576
366: 369
64: 60
1.00
(0.86-1.15)
0.948
1.00
(0.86-1.16)
0.990
185: 239
95: 161
15: 36
0.75
(0.59-0.95)
0.019
0.78
(0.60-1.01)
0.063
385: 331
259: 207
47: 23
1.18
(0.98-1.42)
0.080
1.18
(0.98-1.43)
0.080
rs873079 (G/A) 607: 591
356: 364
56: 50
0.99
(0.86-1.15)
0.927
0.99
(0.85-1.15)
0.861
191: 248
91: 162
13: 26
0.76
(0.59-0.98)
0.036
0.78
(0.59-1.02)
0.065
397: 337
253: 201
41: 23
1.14
(0.94-1.37)
0.186
1.14
(0.94-1.38)
0.176
DK176673 (T/A) 847: 807
107: 110
6: 1
1.02
(0.78-1.33)
0.900
1.04
(0.79-1.37)
0.791
236: 359
38: 43
5: 1
1.55
(1.03-2.34)
0.037
1.58
(1.01-2.46)
0.043
584: 441
63: 66
1: 0
0.75
(0.52-1.07)
0.116
0.76
(0.53-1.09)
0.132
Data are presented as genotype counts. OR (95% CI) stands for odds ratio with 95% confidence interval assuming additive model. ORadj and Padj were calculated
by logistic regression analysis after adjustments for age, sex and BMI.
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significant after permutation analyses (haplotype fre-
quencies of 19.5% and 24.1% among type 2 diabetes
patients and controls respectively; OR = 0.76, P/Pperm =
0.038/0.242).
DOK5 polymorphisms and obesity
Association of DOK5 variants with obesity was assessed
by considering BMI both as continuous and discrete
trait (≥23 kg/m
2) among control subjects. SNP
rs6064099 was significantly associated with reduced
BMI [median(IQR) = 24.0(20.7-27.1) vs 23.9(20.2-26.8)
vs 21.8(19.2-24.7) for GG vs GC vs CC, P =7 . 0×1 0
-3].
Considering BMI as a discrete trait, we observed signifi-
cant association of rs6064099 with obesity (OR = 0.48,
P =6 . 8×1 0
-3) that remained significant after adjusting
for age and sex (P =9 . 8×1 0
-3). We also found signifi-
cant association of GGC haplotype with obesity. GGC
haplotype was over-represented among over-weight/
obese subjects (65.4%) compared to normal-weight sub-
jects (59.7%), conferring risk for obesity with OR of 1.27
[P = 9.0 × 10
-3/Pperm = 0.039].
DOK5 polymorphisms and quantitative clinical traits
Further, we investigated association of DOK5 SNPs with
quantitative traits related to type 2 diabetes including fast-
ing glucose, HbA1c, insulin, C-peptide, hsCRP, total cho-
lesterol, HDL, LDL, triglyceride, creatinine, urea and uric
acid. For this, the clinical variables of only control subjects
were compared across the genotypes of the SNPs as the
disease status or treatment regime in patients might affect
the estimation of these parameters. However, none of the
SNPs was found to be significantly associated with the
clinical traits investigated here (all P > 0.05).
Discussion
Indian population represents the highest risk group for
type 2 diabetes and related metabolic traits including
obesity and cardiovascular diseases. A number of associa-
tion studies have been performed in Indian population to
evaluate the role of functional candidate genes, most of
which involves replication of associations in other popu-
lations. Moreover, these efforts have not yielded any true
susceptibility gene that causes type 2 diabetes in this high
risk group. With the advent of genome-wide association
(GWA) studies, there has been a sudden increase in the
number of confirmed loci for type 2 diabetes [26]. How-
ever, these identified loci contribute only to a small pro-
portion of expected number of involved genes [27].
Hence, along with the model free approach of GWA stu-
dies, positional candidate approach targeting genes with
plausible functional relevance can substantially contri-
bute to a better understanding of the complex disorders.
Therefore, here, we investigated a potential positional
and functional candidate gene, DOK5 on chromosomal
region 20q13, to identify novel susceptibility gene for
type 2 diabetes and obesity.
Association analysis of DOK5 SNPs revealed signifi-
cant association of its variants with type 2 diabetes
among normal-weight subjects. SNPs rs6064099 in
intron 6 and rs873079 in intron 7 were found to reduce
the susceptibility to type 2 diabetes among normal-
weight individuals. Also, the novel SNP DK176673 was
found to confer susceptibility to type 2 diabetes. Nor-
mal-weight individuals harboring haplotype GGC of
major alleles for SNPs rs6068915, rs6064099 and
rs873079 were found to be more susceptible to type 2
diabetes. Hence, our data suggests that DOK5 might
play a significant role in modulating the susceptibility of
type 2 diabetes among normal-weight subjects in North
Indian population. Our study further reinforces our ear-
lier observations that etiologic mechanisms of pathophy-
siology of type 2 diabetes depend on BMI [11,24].
Consistent with earlier observations of linkage of
20q13 with obesity, our study also provides added evi-
dence for the localization of susceptibility gene for obe-
sity in this region. We found strong association of
rs6064099 with protection against obesity. Also, GGC
haplotype was found to confer increased susceptibility
to obesity. Association of DOK5 variants with obesity
again suggests that these variants may modulate the sus-
ceptibility to type 2 diabetes through obesity.
It is interesting to note the GGC haplotype region
harboring three SNPs rs6068916, rs6064099 and
rs873079, encompasses exons 6 and 7 of DOK5 gene. In
case if these associated SNPs are not true causal var-
iants, there might be a causal or functionally relevant
variant in LD with the associated SNPs influencing the
Table 3 Association of haplotype GGC with type 2 diabetes and obesity in North Indian population
Subjects Haplotype Frequency OR (95%CI) P value Pperm value
Type 2 diabetic patients 66.9 1.37 (1.10-1.70) 0.0058 0.037
Non-diabetic controls 59.8
NW controls 59.7 1.27 (1.06-1.53) 0.009 0.039
OW controls 65.4
Haplotype frequencies are provided in percentages. NW stands for normal-weight subjects whereas OW stands for over-weight/obese subjects; OR (95% CI)
stands for odds ratio with 95% confidence interval. Pperm represents the P values obtained after performing 10,000 permutations.
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attempted to identify all the polymorphisms in exonic
regions, there might be possibility of less common var-
iants with higher relative risks in these regions that
could not be captured in our sequenced samples.
Hence, further evaluation of SNPs in DOK5 in a larger
population might provide true susceptibility variant in
DOK5 gene.
We would like to mention here that production of
false positives in association studies due to population
stratification and multiple comparisons might be plausi-
ble. With this in mind, our case and control subjects
were recruited from a homogenous cluster in urban
region of North India in accordance to a report of
genetic landscape of the people of India [28]. From the
clustering pattern, it was suggested that if cases and
controls are both drawn from the same cluster, the
effects of population stratification in disease association
studies may be small. Another study analyzing Indian
genetic variation and diversity also suggested that the
effects of population heterogeneity on the production of
false positives in association studies might be smaller in
Indians than might be expected for such a geographi-
cally and linguistically diverse subset of the human
population [29].
Conclusions
In conclusion, we identified DOK5 as a novel gene modu-
lating the susceptibility of obesity and diabetes in North
Indian population of Indo-European ethnicity. However,
replication analyses of the variants showing association in
this study are warranted to validate the findings. More-
over, other genetic variants in the gene might also play
role in influencing the risk of type 2 diabetes. Therefore,
future genetic and functional studies evaluating the asso-
ciation of genetic variants of DOK5 and deciphering their
physiological effect and mechanisms are needed to further
ascertain its role in the manifestation of type 2 diabetes.
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